Riptide Bioscience Wins Highest Award at Annual Defense Department Research Review

November 15, 2016

SAN FRANCISCO, CA. – Riptide Bioscience, Inc., today announced that it has won the Gold Award for Excellence at the 2016 Military Health Systems Research Symposium (MHSRS).

Read more >

Riptide Bioscience Announces Cooperative Research and Development Agreement with the National Cancer Institute

October 3, 2016

SAN FRANCISCO, CA. – Henry Lopez, Executive Vice President of Riptide Bioscience, Inc., today announced the execution of a Cooperative Research and Development Agreement (NCI CRADA #03045) with the National Cancer Institute (NCI), part of the National Institutes of Health.

Read more >

Riptide Bioscience President to Address AACR Conference

January 10, 2016

SAN FRANCISCO, CA. – Dr. George R. Martin, President of Riptide Bioscience, delivered an invited presentation to the American Association for Cancer Research (AACR) Special Conference on "The Function of Tumor Microenvironment in Cancer Progression," held in San Diego, California, on January 7 - 10, 2016.

Read more >

Thompson Announces $1.5 Million Defense Department Grant for Riptide Bioscience

October 9, 2015

WASHINGTON D.C. – U.S. Rep. Mike Thompson (CA-5) today announced a $1.5 million Defense Department grant for Riptide Bioscience, Inc. Riptide Bioscience is based in Vallejo on Mare Island.

Read more >

Riptide Bioscience, Inc. Begins Research Under $222,000 NEI Grant

October 1, 2014

SAN FRANCISCO, CA. – Charles Garvin, CEO of Riptide Bioscience, Inc., announced Riptide's initiation of work under a $222,179 Small Business Innovation Research federal grant. The grant, from the National Eye Institute (NEI), will go towards a research project titled Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.

Read more >


Previous page < Additional articles >